fidarestat has been researched along with Diabetic Retinopathy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, T; Matsubara, A; Ogura, Y; Taniguchi, K | 1 |
| Hibi, C | 1 |
| Akagi, Y; Kubo, E | 1 |
| Ali, TK; Drel, VR; El-Remessy, AB; Julius, U; Obrosova, IG; Pacher, P; Shin, J | 1 |
2 review(s) available for fidarestat and Diabetic Retinopathy
| Article | Year |
|---|---|
[Fidarestat (SNK-860)].
Topics: Aldehyde Reductase; Animals; Clinical Trials, Phase III as Topic; Diabetic Neuropathies; Diabetic Retinopathy; Endothelial Growth Factors; Humans; Hypoglycemic Agents; Imidazoles; Imidazolidines; Intercellular Signaling Peptides and Proteins; Lymphokines; Neural Conduction; Neurons, Afferent; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
[Role of aldose reductase in the progression of diabetic retinopathies].
Topics: Aldehyde Reductase; Animals; Apoptosis; Clinical Trials as Topic; Diabetic Retinopathy; Humans; Imidazolidines; Macular Edema; Polymorphism, Genetic; Retina | 2005 |
2 other study(ies) available for fidarestat and Diabetic Retinopathy
| Article | Year |
|---|---|
Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Topics: Acridine Orange; Administration, Oral; Aldehyde Reductase; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Fluorophotometry; Fructose; Imidazolidines; Intercellular Adhesion Molecule-1; Leukocytes; Male; Microscopy, Fluorescence; Rats; Rats, Long-Evans; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sorbitol; Vascular Endothelial Growth Factor A | 2010 |
Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
Topics: Aldehyde Reductase; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blood Glucose; Blotting, Western; Cataract; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glial Fibrillary Acidic Protein; Imidazolidines; Immunohistochemistry; In Situ Nick-End Labeling; Neuroglia; Ophthalmoscopy; Oxidative Stress; Poly(ADP-ribose) Polymerases; Rats; Retina; Streptozocin; Tyrosine | 2008 |